Limba
Romanian
Romanian
English|
Nurulimab (Anti-CTLA-4 / CD152), 1mg*5
6.475,98 RON
SKU
SKM_A2859_1mg*5
Nurulimab (Anti-CTLA-4 / CD152) is a monoclonal antibody directed against the human T-cell-expressed receptor cytotoxic T-lymphocyte-associated antigen 4 (CTLA4, CTLA-4), with potential immune checkpoint inhibitory and antineoplastic activities. MW: 145.34 KD.
| Price | 5.442,00 RON (preturile sunt fara TVA) |
|---|---|
| Description |
Nurulimab (Anti-CTLA-4 / CD152) is a monoclonal antibody directed against the human T-cell-expressed receptor cytotoxic T-lymphocyte-associated antigen 4 (CTLA4, CTLA-4), with potential immune checkpoint inhibitory and antineoplastic activities. MW: 145.34 KD. |
